Best practices for risk monitoring and supply chain visibility
Kessing LV, Rytgaard HC, Ekstrm CT, Knop FK, Berk M, Gerds TA
Learn more about what's happening and the choices you have based on your condition, lifestyle, and budget
7, 2025 (HealthDay News) Two major drugmakers will slash the price of popular weight loss medications for some Americans, including people on Medicare and Medicaid, President Donald Trump announced Thursday
But as a Wired article from August put it, the Ozempic-adjacent supplement gold rush is just getting started. Because of how these drugs work, their desired effects and their many unpleasant side effects, supplements can indeed be a key component of the GLP-1 journey
In Korea, Novo Nordisk has obtained the license for Saxenda, Wegovy, and Ozempic but only Saxenda is currently on the market